bearish
Bionote Pre-IPO - The Negatives - Fortunes Generated from a Sole Related Party
299 Views22 Oct 2022 09:29
Bionote (377740 KS) is looking to raise approximately US$200m in its Korean IPO. The IPO would consist of both a primary and secondary selldown.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Bionote IPO Trading - Weakest Demand Even After Cutting Price and Size21 Dec 2022
- Bionote Pre-IPO - Thoughts on Valuation08 Nov 2022
- Bionote Pre-IPO Peer Comp - Larger Segment Leads in Margins, but Trend Could Be Reversing03 Nov 2022
- Bionote Pre-IPO - The Positives - Expanding Product Portfolio and Vertically Integrated20 Oct 2022
x